Tejnaksh Healthcare Ltd

Tejnaksh Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 9 February 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite a very attractive valuation, the company’s flat financial performance, declining profitability, and bearish technical trends have prompted a reassessment of its outlook within the Healthcare Services sector.

Tejnaksh Healthcare Ltd., a Mumbai-based speciality urology hospital operator, reported a consolidated net profit of ₹0.30 crores for Q3 FY26, marking a sharp 50.82% decline year-on-year from ₹0.61 crores in Q3 FY25. The micro-cap company, with a market capitalisation of ₹32.00 crores, witnessed its third consecutive quarter of revenue contraction, raising concerns about operational sustainability in an otherwise resilient healthcare services sector.

Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing challenges in financial performance and valuation metrics. The company’s technical trend has improved from bearish to mildly bearish, prompting a reassessment of its market stance. However, fundamental weaknesses and valuation concerns continue to weigh on investor sentiment.

Tejnaksh Healthcare Ltd’s shares declined sharply to a fresh 52-week low of Rs.12.55 on 27 Jan 2026, marking a significant milestone in the stock’s downward trajectory amid broader market weakness and company-specific performance concerns.

Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 2 January 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The healthcare services company’s Mojo Score improved to 31.0, reflecting a nuanced market view that balances technical recovery against ongoing financial underperformance and valuation considerations.

Tejnaksh Healthcare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Dec 2025. However, all fundamentals, returns, and financial metrics discussed below reflect the stock’s current position as of 26 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Tejnaksh Healthcare’s shares reached a fresh 52-week low of Rs.14.01 today, marking a significant decline amid ongoing challenges in the healthcare services sector. The stock’s performance continues to trail behind key market indices and sector benchmarks, reflecting persistent pressures on the company’s financial metrics and valuation.

Tejnaksh Healthcare has reached a new 52-week low, with its share price touching Rs.15.15 today. This marks a significant decline for the healthcare services company amid broader market fluctuations and ongoing performance concerns.

Tejnaksh Healthcare, a player in the healthcare services sector, has recently experienced a notable shift in market evaluation metrics. This change reflects a complex interplay of technical indicators, valuation considerations, financial trends, and quality assessments, highlighting the challenges the company faces amid a subdued market environment and persistent underperformance relative to benchmarks.

Tejnaksh Healthcare’s stock price reached a fresh 52-week low of Rs.16 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past four consecutive sessions, reflecting ongoing pressures within the healthcare services sector.

Tejnaksh Healthcare, a player in the healthcare services sector, has experienced a notable revision in its market evaluation, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments. This article analyses the factors influencing the recent shift in the company’s investment outlook, providing investors with a comprehensive understanding of its current position.

Tejnaksh Healthcare has reached a new 52-week low, with its share price touching Rs.16.02 today. This marks a significant decline amid broader market fluctuations and ongoing challenges within the healthcare services sector.

Tejnaksh Healthcare, a key player in the Healthcare Services sector, has undergone a revision in its evaluation reflecting changes across technical indicators, financial trends, valuation metrics, and overall quality parameters. This article analyses the factors influencing the recent adjustment in the company’s score grade as of 19 Nov 2025, providing investors with a comprehensive overview of its current standing.